Acetylcholinesterase inhibitory guided fractionation of Melissa officinalis L

Acetylcholinesterase guided fractionation of Melissa officinalis L. was carried out and the contents out and the contents of the most potent fraction were identified as cis- and trans-rosmarinic acids and a derivative of rosmarinic acid. The plant Melissa officinalis L. has been used traditionally i...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Bioorganic & medicinal chemistry 2009-01, Vol.17 (2), p.867-871
Hauptverfasser: Dastmalchi, Keyvan, Ollilainen, Velimatti, Lackman, Petri, Gennäs, Gustav Boije af, Dorman, H.J. Damien, Järvinen, Päivi P., Yli-Kauhaluoma, Jari, Hiltunen, Raimo
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 871
container_issue 2
container_start_page 867
container_title Bioorganic & medicinal chemistry
container_volume 17
creator Dastmalchi, Keyvan
Ollilainen, Velimatti
Lackman, Petri
Gennäs, Gustav Boije af
Dorman, H.J. Damien
Järvinen, Päivi P.
Yli-Kauhaluoma, Jari
Hiltunen, Raimo
description Acetylcholinesterase guided fractionation of Melissa officinalis L. was carried out and the contents out and the contents of the most potent fraction were identified as cis- and trans-rosmarinic acids and a derivative of rosmarinic acid. The plant Melissa officinalis L. has been used traditionally in the treatment of cognitive dysfunction. Based on its traditional medicinal use, it was assessed for its clinical efficacy in mild to moderate Alzheimer’s patients. The plant was effective in the management of the disease. Therefore, based on this result, a similar plant extract was prepared in order to be screened for bioactivities which are relevant in Alzheimer’s disease therapy. The extract was recently screened for antioxidant activity and it showed a wide range of antioxidant properties. Another important bioactivity is acetylcholinesterase inhibition, which the extract was screened for in the current investigation. The extract was capable of inhibiting the enzyme in a time and dose-dependent manner. Activity of the extract at 10 min was estimated as 1.72 ± 0.16 μg equivalents of physostigmine/mg of the extract. Acetylcholinesterase inhibitory guided fractionation of the extract was then carried out. Most of the fractions showed inhibitory activity and were more potent than the extract. The contents of the most potent fraction were identified as cis- and trans-rosmarinic acid isomers and a rosmarinic acid derivative using LC-DAD-ESI-MS and NMR methods.
doi_str_mv 10.1016/j.bmc.2008.11.034
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_66846589</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0968089608011115</els_id><sourcerecordid>20348037</sourcerecordid><originalsourceid>FETCH-LOGICAL-c478t-47b71f3189b8c3b2cfe7126e99116854793cbfa6b9c0b9315d4da5c9a303825a3</originalsourceid><addsrcrecordid>eNqFkE1P3DAQhi3UqizQH9BLlUt7S_DEjmOLE0LlQ1rUSzlb9mQCXmUTsLNI--_r1a7gBhePR3re0czD2A_gFXBQ56vKr7GqOdcVQMWFPGILkEqWQhj4whbcKF1ybdQxO0lpxTmvpYFv7BgMb7k0esHuL5Hm7YBP0xBGSjNFl6gI41PwYZ7itnjchI66oo8O5zCNbvcUU1_c0xBScvnbBwyjy12xPGNfezck-n6op-zh-s-_q9ty-ffm7upyWaJs9VzK1rfQC9DGaxS-xp5aqBUZA6B0I1sj0PdOeYPcGwFNJzvXoHGCC103Tpyy3_u5z3F62eS17TokpGFwI02bZJXSUjXafArWWZrmos0g7EGMU0qRevscw9rFrQVud7LtymbZdifbAticy5mfh-Ebv6buPXGwm4FfB8AldEN2OGJIb1wNUOe7m8xd7DnKzl4DRZsw0IjUhUg4224KH6zxH6SQnFo</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>20348037</pqid></control><display><type>article</type><title>Acetylcholinesterase inhibitory guided fractionation of Melissa officinalis L</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Dastmalchi, Keyvan ; Ollilainen, Velimatti ; Lackman, Petri ; Gennäs, Gustav Boije af ; Dorman, H.J. Damien ; Järvinen, Päivi P. ; Yli-Kauhaluoma, Jari ; Hiltunen, Raimo</creator><creatorcontrib>Dastmalchi, Keyvan ; Ollilainen, Velimatti ; Lackman, Petri ; Gennäs, Gustav Boije af ; Dorman, H.J. Damien ; Järvinen, Päivi P. ; Yli-Kauhaluoma, Jari ; Hiltunen, Raimo</creatorcontrib><description>Acetylcholinesterase guided fractionation of Melissa officinalis L. was carried out and the contents out and the contents of the most potent fraction were identified as cis- and trans-rosmarinic acids and a derivative of rosmarinic acid. The plant Melissa officinalis L. has been used traditionally in the treatment of cognitive dysfunction. Based on its traditional medicinal use, it was assessed for its clinical efficacy in mild to moderate Alzheimer’s patients. The plant was effective in the management of the disease. Therefore, based on this result, a similar plant extract was prepared in order to be screened for bioactivities which are relevant in Alzheimer’s disease therapy. The extract was recently screened for antioxidant activity and it showed a wide range of antioxidant properties. Another important bioactivity is acetylcholinesterase inhibition, which the extract was screened for in the current investigation. The extract was capable of inhibiting the enzyme in a time and dose-dependent manner. Activity of the extract at 10 min was estimated as 1.72 ± 0.16 μg equivalents of physostigmine/mg of the extract. Acetylcholinesterase inhibitory guided fractionation of the extract was then carried out. Most of the fractions showed inhibitory activity and were more potent than the extract. The contents of the most potent fraction were identified as cis- and trans-rosmarinic acid isomers and a rosmarinic acid derivative using LC-DAD-ESI-MS and NMR methods.</description><identifier>ISSN: 0968-0896</identifier><identifier>EISSN: 1464-3391</identifier><identifier>DOI: 10.1016/j.bmc.2008.11.034</identifier><identifier>PMID: 19070498</identifier><language>eng</language><publisher>Amsterdam: Elsevier Ltd</publisher><subject>Acetylcholinesterase inhibition ; Activity-guided fractionation ; Alzheimer Disease - drug therapy ; Antioxidants - isolation &amp; purification ; Antioxidants - pharmacology ; Aroma and flavouring agent industries ; Biological and medical sciences ; Cholinesterase Inhibitors - isolation &amp; purification ; Cholinesterase Inhibitors - pharmacology ; Cinnamates ; cis-Rosmarinic acid ; Depsides ; Food industries ; Fundamental and applied biological sciences. Psychology ; General pharmacology ; Humans ; Kinetics ; Medical sciences ; Melissa - chemistry ; Melissa officinalis ; Pharmacognosy. Homeopathy. Health food ; Pharmacology. Drug treatments ; Plant Extracts - chemistry ; Rosmarinic Acid ; trans-Rosmarinic acid</subject><ispartof>Bioorganic &amp; medicinal chemistry, 2009-01, Vol.17 (2), p.867-871</ispartof><rights>2008 Elsevier Ltd</rights><rights>2009 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c478t-47b71f3189b8c3b2cfe7126e99116854793cbfa6b9c0b9315d4da5c9a303825a3</citedby><cites>FETCH-LOGICAL-c478t-47b71f3189b8c3b2cfe7126e99116854793cbfa6b9c0b9315d4da5c9a303825a3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0968089608011115$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=21127125$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/19070498$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Dastmalchi, Keyvan</creatorcontrib><creatorcontrib>Ollilainen, Velimatti</creatorcontrib><creatorcontrib>Lackman, Petri</creatorcontrib><creatorcontrib>Gennäs, Gustav Boije af</creatorcontrib><creatorcontrib>Dorman, H.J. Damien</creatorcontrib><creatorcontrib>Järvinen, Päivi P.</creatorcontrib><creatorcontrib>Yli-Kauhaluoma, Jari</creatorcontrib><creatorcontrib>Hiltunen, Raimo</creatorcontrib><title>Acetylcholinesterase inhibitory guided fractionation of Melissa officinalis L</title><title>Bioorganic &amp; medicinal chemistry</title><addtitle>Bioorg Med Chem</addtitle><description>Acetylcholinesterase guided fractionation of Melissa officinalis L. was carried out and the contents out and the contents of the most potent fraction were identified as cis- and trans-rosmarinic acids and a derivative of rosmarinic acid. The plant Melissa officinalis L. has been used traditionally in the treatment of cognitive dysfunction. Based on its traditional medicinal use, it was assessed for its clinical efficacy in mild to moderate Alzheimer’s patients. The plant was effective in the management of the disease. Therefore, based on this result, a similar plant extract was prepared in order to be screened for bioactivities which are relevant in Alzheimer’s disease therapy. The extract was recently screened for antioxidant activity and it showed a wide range of antioxidant properties. Another important bioactivity is acetylcholinesterase inhibition, which the extract was screened for in the current investigation. The extract was capable of inhibiting the enzyme in a time and dose-dependent manner. Activity of the extract at 10 min was estimated as 1.72 ± 0.16 μg equivalents of physostigmine/mg of the extract. Acetylcholinesterase inhibitory guided fractionation of the extract was then carried out. Most of the fractions showed inhibitory activity and were more potent than the extract. The contents of the most potent fraction were identified as cis- and trans-rosmarinic acid isomers and a rosmarinic acid derivative using LC-DAD-ESI-MS and NMR methods.</description><subject>Acetylcholinesterase inhibition</subject><subject>Activity-guided fractionation</subject><subject>Alzheimer Disease - drug therapy</subject><subject>Antioxidants - isolation &amp; purification</subject><subject>Antioxidants - pharmacology</subject><subject>Aroma and flavouring agent industries</subject><subject>Biological and medical sciences</subject><subject>Cholinesterase Inhibitors - isolation &amp; purification</subject><subject>Cholinesterase Inhibitors - pharmacology</subject><subject>Cinnamates</subject><subject>cis-Rosmarinic acid</subject><subject>Depsides</subject><subject>Food industries</subject><subject>Fundamental and applied biological sciences. Psychology</subject><subject>General pharmacology</subject><subject>Humans</subject><subject>Kinetics</subject><subject>Medical sciences</subject><subject>Melissa - chemistry</subject><subject>Melissa officinalis</subject><subject>Pharmacognosy. Homeopathy. Health food</subject><subject>Pharmacology. Drug treatments</subject><subject>Plant Extracts - chemistry</subject><subject>Rosmarinic Acid</subject><subject>trans-Rosmarinic acid</subject><issn>0968-0896</issn><issn>1464-3391</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2009</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkE1P3DAQhi3UqizQH9BLlUt7S_DEjmOLE0LlQ1rUSzlb9mQCXmUTsLNI--_r1a7gBhePR3re0czD2A_gFXBQ56vKr7GqOdcVQMWFPGILkEqWQhj4whbcKF1ybdQxO0lpxTmvpYFv7BgMb7k0esHuL5Hm7YBP0xBGSjNFl6gI41PwYZ7itnjchI66oo8O5zCNbvcUU1_c0xBScvnbBwyjy12xPGNfezck-n6op-zh-s-_q9ty-ffm7upyWaJs9VzK1rfQC9DGaxS-xp5aqBUZA6B0I1sj0PdOeYPcGwFNJzvXoHGCC103Tpyy3_u5z3F62eS17TokpGFwI02bZJXSUjXafArWWZrmos0g7EGMU0qRevscw9rFrQVud7LtymbZdifbAticy5mfh-Ebv6buPXGwm4FfB8AldEN2OGJIb1wNUOe7m8xd7DnKzl4DRZsw0IjUhUg4224KH6zxH6SQnFo</recordid><startdate>20090115</startdate><enddate>20090115</enddate><creator>Dastmalchi, Keyvan</creator><creator>Ollilainen, Velimatti</creator><creator>Lackman, Petri</creator><creator>Gennäs, Gustav Boije af</creator><creator>Dorman, H.J. Damien</creator><creator>Järvinen, Päivi P.</creator><creator>Yli-Kauhaluoma, Jari</creator><creator>Hiltunen, Raimo</creator><general>Elsevier Ltd</general><general>Elsevier</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QO</scope><scope>8FD</scope><scope>FR3</scope><scope>P64</scope><scope>7X8</scope></search><sort><creationdate>20090115</creationdate><title>Acetylcholinesterase inhibitory guided fractionation of Melissa officinalis L</title><author>Dastmalchi, Keyvan ; Ollilainen, Velimatti ; Lackman, Petri ; Gennäs, Gustav Boije af ; Dorman, H.J. Damien ; Järvinen, Päivi P. ; Yli-Kauhaluoma, Jari ; Hiltunen, Raimo</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c478t-47b71f3189b8c3b2cfe7126e99116854793cbfa6b9c0b9315d4da5c9a303825a3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2009</creationdate><topic>Acetylcholinesterase inhibition</topic><topic>Activity-guided fractionation</topic><topic>Alzheimer Disease - drug therapy</topic><topic>Antioxidants - isolation &amp; purification</topic><topic>Antioxidants - pharmacology</topic><topic>Aroma and flavouring agent industries</topic><topic>Biological and medical sciences</topic><topic>Cholinesterase Inhibitors - isolation &amp; purification</topic><topic>Cholinesterase Inhibitors - pharmacology</topic><topic>Cinnamates</topic><topic>cis-Rosmarinic acid</topic><topic>Depsides</topic><topic>Food industries</topic><topic>Fundamental and applied biological sciences. Psychology</topic><topic>General pharmacology</topic><topic>Humans</topic><topic>Kinetics</topic><topic>Medical sciences</topic><topic>Melissa - chemistry</topic><topic>Melissa officinalis</topic><topic>Pharmacognosy. Homeopathy. Health food</topic><topic>Pharmacology. Drug treatments</topic><topic>Plant Extracts - chemistry</topic><topic>Rosmarinic Acid</topic><topic>trans-Rosmarinic acid</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Dastmalchi, Keyvan</creatorcontrib><creatorcontrib>Ollilainen, Velimatti</creatorcontrib><creatorcontrib>Lackman, Petri</creatorcontrib><creatorcontrib>Gennäs, Gustav Boije af</creatorcontrib><creatorcontrib>Dorman, H.J. Damien</creatorcontrib><creatorcontrib>Järvinen, Päivi P.</creatorcontrib><creatorcontrib>Yli-Kauhaluoma, Jari</creatorcontrib><creatorcontrib>Hiltunen, Raimo</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Biotechnology Research Abstracts</collection><collection>Technology Research Database</collection><collection>Engineering Research Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Bioorganic &amp; medicinal chemistry</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Dastmalchi, Keyvan</au><au>Ollilainen, Velimatti</au><au>Lackman, Petri</au><au>Gennäs, Gustav Boije af</au><au>Dorman, H.J. Damien</au><au>Järvinen, Päivi P.</au><au>Yli-Kauhaluoma, Jari</au><au>Hiltunen, Raimo</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Acetylcholinesterase inhibitory guided fractionation of Melissa officinalis L</atitle><jtitle>Bioorganic &amp; medicinal chemistry</jtitle><addtitle>Bioorg Med Chem</addtitle><date>2009-01-15</date><risdate>2009</risdate><volume>17</volume><issue>2</issue><spage>867</spage><epage>871</epage><pages>867-871</pages><issn>0968-0896</issn><eissn>1464-3391</eissn><abstract>Acetylcholinesterase guided fractionation of Melissa officinalis L. was carried out and the contents out and the contents of the most potent fraction were identified as cis- and trans-rosmarinic acids and a derivative of rosmarinic acid. The plant Melissa officinalis L. has been used traditionally in the treatment of cognitive dysfunction. Based on its traditional medicinal use, it was assessed for its clinical efficacy in mild to moderate Alzheimer’s patients. The plant was effective in the management of the disease. Therefore, based on this result, a similar plant extract was prepared in order to be screened for bioactivities which are relevant in Alzheimer’s disease therapy. The extract was recently screened for antioxidant activity and it showed a wide range of antioxidant properties. Another important bioactivity is acetylcholinesterase inhibition, which the extract was screened for in the current investigation. The extract was capable of inhibiting the enzyme in a time and dose-dependent manner. Activity of the extract at 10 min was estimated as 1.72 ± 0.16 μg equivalents of physostigmine/mg of the extract. Acetylcholinesterase inhibitory guided fractionation of the extract was then carried out. Most of the fractions showed inhibitory activity and were more potent than the extract. The contents of the most potent fraction were identified as cis- and trans-rosmarinic acid isomers and a rosmarinic acid derivative using LC-DAD-ESI-MS and NMR methods.</abstract><cop>Amsterdam</cop><pub>Elsevier Ltd</pub><pmid>19070498</pmid><doi>10.1016/j.bmc.2008.11.034</doi><tpages>5</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0968-0896
ispartof Bioorganic & medicinal chemistry, 2009-01, Vol.17 (2), p.867-871
issn 0968-0896
1464-3391
language eng
recordid cdi_proquest_miscellaneous_66846589
source MEDLINE; Elsevier ScienceDirect Journals
subjects Acetylcholinesterase inhibition
Activity-guided fractionation
Alzheimer Disease - drug therapy
Antioxidants - isolation & purification
Antioxidants - pharmacology
Aroma and flavouring agent industries
Biological and medical sciences
Cholinesterase Inhibitors - isolation & purification
Cholinesterase Inhibitors - pharmacology
Cinnamates
cis-Rosmarinic acid
Depsides
Food industries
Fundamental and applied biological sciences. Psychology
General pharmacology
Humans
Kinetics
Medical sciences
Melissa - chemistry
Melissa officinalis
Pharmacognosy. Homeopathy. Health food
Pharmacology. Drug treatments
Plant Extracts - chemistry
Rosmarinic Acid
trans-Rosmarinic acid
title Acetylcholinesterase inhibitory guided fractionation of Melissa officinalis L
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-07T07%3A38%3A46IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Acetylcholinesterase%20inhibitory%20guided%20fractionation%20of%20Melissa%20officinalis%20L&rft.jtitle=Bioorganic%20&%20medicinal%20chemistry&rft.au=Dastmalchi,%20Keyvan&rft.date=2009-01-15&rft.volume=17&rft.issue=2&rft.spage=867&rft.epage=871&rft.pages=867-871&rft.issn=0968-0896&rft.eissn=1464-3391&rft_id=info:doi/10.1016/j.bmc.2008.11.034&rft_dat=%3Cproquest_cross%3E20348037%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=20348037&rft_id=info:pmid/19070498&rft_els_id=S0968089608011115&rfr_iscdi=true